Drug Type Small molecule drug |
Synonyms- |
Target |
Action agonists |
Mechanism 5-HT1A receptor agonists(Serotonin 1a (5-HT1a) receptor agonists), CB2 agonists(Cannabinoid CB2 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Anxiety Disorders | Preclinical | China | 01 Feb 2024 | |
| Anxiety Disorders | Preclinical | China | 01 Feb 2024 | |
| Depressive Disorder | Preclinical | China | 01 Feb 2024 | |
| Depressive Disorder | Preclinical | China | 01 Feb 2024 |





